| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
group | 0.400 | None | 0.974 | 352 | 0 | 1984 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.100 | None | 0.977 | 347 | 0 | 1996 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
phenotype | 0.100 | None | 0.997 | 347 | 0 | 2000 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.997 | 346 | 0 | 2000 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.997 | 345 | 0 | 2000 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
phenotype | 0.100 | None | 0.984 | 322 | 0 | 1998 | 2020 | ||||||||
|
prominin 1 | 0.410 | 0.846 | 1.9E-22 |
|
group | 0.100 | None | 0.984 | 322 | 0 | 2006 | 2020 | ||||||||
|
prominin 1 | 0.410 | 0.846 | 1.9E-22 |
|
group | 0.100 | None | 0.984 | 315 | 0 | 2006 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.100 | None | 0.971 | 311 | 0 | 1992 | 2020 | ||||||||
|
interferon beta 1 | 0.421 | 0.846 |
|
disease | 0.400 | None | 0.958 | 308 | 0 | 1995 | 2020 | |||||||||
|
mannose receptor C-type 1 | 0.413 | 0.846 | 0.94 |
|
group | 0.100 | None | 0.950 | 300 | 0 | 1996 | 2020 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
phenotype | 0.100 | None | 0.987 | 297 | 0 | 1990 | 2020 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
disease | 0.100 | None | 0.966 | 294 | 0 | 2004 | 2020 | ||||||||
|
laminin subunit gamma 2 | 0.389 | 0.923 | 2.9E-12 |
|
disease | 0.100 | None | 0.965 | 289 | 0 | 2010 | 2020 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
disease | 0.100 | None | 0.990 | 288 | 0 | 1986 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0.989 | 283 | 0 | 2000 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0.989 | 280 | 0 | 2005 | 2020 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
group | 0.100 | None | 0.953 | 276 | 0 | 1994 | 2020 | |||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.100 | None | 0.945 | 271 | 0 | 1995 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.100 | None | 0.833 | 269 | 0 | 2008 | 2020 | ||||||||
|
Pulmonary disease, chronic obstructive, severe early-onset | 0.456 | 0.885 |
|
disease | 0.100 | None | 0.970 | 268 | 0 | 2002 | 2020 | |||||||||
|
EWS RNA binding protein 1 | 0.474 | 0.692 | 1.00 |
|
group | 0.100 | None | 0.966 | 262 | 0 | 1994 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.500 | None | 0.981 | 262 | 0 | 1987 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.400 | None | 0.947 | 262 | 0 | 1990 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.992 | 259 | 0 | 2000 | 2020 |